RecruitingNCT04824066

The Role of Wearable Devices in Predicting and Detecting Complications and Adverse Events

Sponsor: Massachusetts General Hospital

Trial Details

ConditionRecovery, Treatment Complication
InterventionDevice: Wearable Device
StatusRecruiting
Participants2,400
Est. Completion1 Jan 2029
Last Updated28 May 2026

Primary Outcome

Early detection of complications and adverse events using machine learning analysis of patient biometric data.; Prediction of the quality of recovery after treatment using patient biometric data.

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: 1. Age 18 years or older 2. Individuals scheduled to undergo one of the following surgical or non-surgical treatments: cardiothoracic surgery, orthopedic surgery, vascular surgery, colorectal surgery, pancreatic surgery, other major abdominal surgeries, treatment for chronic disease, or systemic therapy (i.e., chemotherapy, immunotherapy, or targeted therapy), radiotherapy, or ablation. 3. Amenable to using one of the wearable devices of interest (Fitbit, iWatch, Biostrap). 4. Individuals willing to provide informed consent and who have capacity for all study procedures Exclusion Criteria: 1. Individuals with mental incapacity and/or cognitive impairment that would preclude adequate understanding of, or cooperation with the study protocol. 2. Any pregnant participant.

Trial Sites

Countries

United States
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service